TGFB1 and Alzheimer disease: Caraci et al. (2011) found that compared to healthy elderly individuals, AD patients have lower levels of TGF-β1 in their plasma and serum, and a reduced release of TGF-β1 by circulating peripheral blood cells (Caraci et al., 2011).